A Global Health Survey of People Who Vape but Never Smoked: Protocol for the VERITAS (Vaping Effects: Real-World International Surveillance) Study.

cross-sectional e-cigarette e-cigarettes electronic cigarette health effects pulmonary questionnaire questionnaires real-world use study respiratory respiratory symptoms smoke smoker smokers smoking survey surveys vape vaping

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
28 Mar 2024
Historique:
received: 02 11 2023
accepted: 31 01 2024
revised: 19 12 2023
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: epublish

Résumé

There is only limited information about the health effects of regular vaping. Research on the health status of people who used to smoke faces the challenge that previous smoking may have caused unknown health effects. Only studies of people who vape but have never smoked combustible cigarettes can enable the detection of harms attributable to vaping. Large prospective studies of well-characterized electronic cigarette users with and without a history of combustible cigarette smoking are warranted to establish the long-term effects of regular vaping on respiratory health. We will conduct a global cross-sectional survey of individuals from 6 world regions. Respiratory symptoms will be assessed using a validated questionnaire-the Respiratory Symptom Experience Scale (RSES). Current vapers who are nonusers of other tobacco or nicotine products will be compared with matched controls who are nonusers of vapes and other tobacco or nicotine products. This will be a multicountry, cross-sectional internet-based survey of 750 adults aged ≥18 years who satisfy the criteria for inclusion in either a cohort of people who exclusively vape and who are nonusers of other tobacco or nicotine products ("vapers cohort"; target N=500) or a cohort of nonvapers who are also nonusers of other tobacco or nicotine products ("controls cohort"; target N=250). The primary end point of the study is the RSES score. RSES scores of people in the "vapers cohort" will be compared with those of people in the "controls cohort." Additionally, the study will collect data to characterize patterns of vaping product use among the vapers cohort. Data collection will include information about the age initiation of using vape products, reasons for starting and continuing the use of vape products, specific types of products used, flavors and nicotine strengths of recently used products, as well as the frequency and intensity of product use in the past 30 days. Participant recruitment started in April 2023, and enrollment was completed by November 2023 with 748 participants. Results will be reported in 2024. This will be the first study providing key insights into respiratory health effects associated with using electronic cigarettes in people who vape with no established use of combustible cigarettes or other tobacco or nicotine products. DERR1-10.2196/54236.

Sections du résumé

BACKGROUND BACKGROUND
There is only limited information about the health effects of regular vaping. Research on the health status of people who used to smoke faces the challenge that previous smoking may have caused unknown health effects. Only studies of people who vape but have never smoked combustible cigarettes can enable the detection of harms attributable to vaping. Large prospective studies of well-characterized electronic cigarette users with and without a history of combustible cigarette smoking are warranted to establish the long-term effects of regular vaping on respiratory health.
OBJECTIVE OBJECTIVE
We will conduct a global cross-sectional survey of individuals from 6 world regions. Respiratory symptoms will be assessed using a validated questionnaire-the Respiratory Symptom Experience Scale (RSES). Current vapers who are nonusers of other tobacco or nicotine products will be compared with matched controls who are nonusers of vapes and other tobacco or nicotine products.
METHODS METHODS
This will be a multicountry, cross-sectional internet-based survey of 750 adults aged ≥18 years who satisfy the criteria for inclusion in either a cohort of people who exclusively vape and who are nonusers of other tobacco or nicotine products ("vapers cohort"; target N=500) or a cohort of nonvapers who are also nonusers of other tobacco or nicotine products ("controls cohort"; target N=250). The primary end point of the study is the RSES score. RSES scores of people in the "vapers cohort" will be compared with those of people in the "controls cohort." Additionally, the study will collect data to characterize patterns of vaping product use among the vapers cohort. Data collection will include information about the age initiation of using vape products, reasons for starting and continuing the use of vape products, specific types of products used, flavors and nicotine strengths of recently used products, as well as the frequency and intensity of product use in the past 30 days.
RESULTS RESULTS
Participant recruitment started in April 2023, and enrollment was completed by November 2023 with 748 participants. Results will be reported in 2024.
CONCLUSIONS CONCLUSIONS
This will be the first study providing key insights into respiratory health effects associated with using electronic cigarettes in people who vape with no established use of combustible cigarettes or other tobacco or nicotine products.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/54236.

Identifiants

pubmed: 38546715
pii: v13i1e54236
doi: 10.2196/54236
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e54236

Informations de copyright

©Jeffrey Zamora Goicoechea, Allison Boughner, Juan José Cirion Lee, Aman Mahajan, Kurt Yeo, Maris Sproga, Tasmin Patel, Claudio Saitta, Christopher Russell, Michael Coughlan, Pasquale Caponnetto, Riccardo Polosa. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 28.03.2024.

Auteurs

Jeffrey Zamora Goicoechea (J)

International Network of Nicotine Consumer Organisations, Vejle, Denmark.
Asociación de Reducción de Daños del Tabaquismo, Bogota, Colombia.
Asociación de usuarios de vaporizadores y métodos de reducción de daños por tabaquismo de Costa Rica, San José, Costa Rica.

Allison Boughner (A)

American Vapor Manufacturers, Prescott, AZ, United States.
South Carolina Vapor Association, Charleston, SC, United States.

Juan José Cirion Lee (JJ)

México y el Mundo Vapeando, Mexico City, Mexico.

Kurt Yeo (K)

Vaping Saved My Life, Benoni, Gauteng, South Africa.
World Vapers Alliance, Miami, FL, United States.

Tasmin Patel (T)

Confidosoft Ltd, Leatherhead, London, United Kingdom.

Claudio Saitta (C)

ECLAT Srl, University of Catania, Catania, Italy.

Christopher Russell (C)

Russell Burnett Research and Consultancy Ltd, Glasgow, United Kingdom.

Michael Coughlan (M)

ECLAT Srl, University of Catania, Catania, Italy.

Pasquale Caponnetto (P)

Section of Psychology, Department of Science of Education, University of Catania, Catania, Italy.
Center of Excellence for the Acceleration of Harm Reduction, University of Catania, Catana, Italy.

Riccardo Polosa (R)

Center of Excellence for the Acceleration of Harm Reduction, University of Catania, Catana, Italy.
Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Classifications MeSH